- Tags: IOLs
Products
SpyGlass Pharma: New add-on CPT code supports BIM-IOL System
AMA approves application in conjunction with Category I cataract surgery codes; applies to investigational bimatoprost delivery system for IOP reduction in OAG and OHT.
Research
Are blue-light blocking IOLs actually effective?
Yellow-tinted lenses were associated with a decline in macular pigment density over 3 years, the opposite of the intended effect.
Events
ASCRS 2026 highlights key trends in surgical ecosystem
Annual meeting of cataract and refractive surgeons kicks off in the nation’s capital with focus on developments in surgical devices and IOLs.
Products
Alcon launches Clareon TruPlus monofocal and toric IOL
Latest next-gen IOL features the new Opti-Blance Technology design to increase DOF without sacrificing distance vision quality
Products
VirtuaLens launches monovision simulation for VR IOL simulator
Immersive virtual reality IOL patient education system allows patients to “try on” lens options in a virtual setting ahead of cataract surgery.Research
High myopes face increased PCO risk with hydrophilic IOLs
Study finds hydrophobic IOLs reduced the risk of PCO in highly myopic eyes by 41%.
Products
FDA approves J&J's TECNIS PureSee IOL for cataract patients
Approval is the first extended-depth-of-focus lens with no warning on loss of contrast sensitivity; availability to follow later this year.
Products
FDA approves expanded age indication for STAAR's EVO/EVO+ Visian ICLs
U.S. age indication now includes patients aged 21 to 60 years old, making nearly 8 million refractive patients eligible for implantable collamer lens implantation.
Products
BVI reports first US implantations of FINEVISION HP Trifocal IOL
Surgeon-led rollout includes five successful procedures across the country of the FDA-approved, presbyopia-correcting lens.
Research
Study: enVista Aspire IOL delivers expanded intermediate vision without sacrificing distance
Prospective study evaluates the enhanced monofocal IOL among patients undergoing standard phaco.Products
FDA approves BVI Medical's FINEVISION HP trifocal IOL
Third-generation premium lens features a unique diffractive design while utilizing the proprietary CoPODize technology for minimized visual disturbances.
Products
FDA approves Rayner's RayOne EMV Toric IOL
Newest lens offers high-quality visual outcomes for patients with astigmatism, including monofocal levels of contrast sensitivity, and low dysphotopsia.
Research
Pivotal study showcases enVista Envy IOL's full range of vision
Data includes meeting all efficacy and safety outcomes, with the lens demonstrating statistical superiority in visual outcomes and a favorable dysphotopsia profile.
Products
VirtuaLens launches with VR-based IOL simulator
New company debuts a first-of-its-kind, customizable VR simulator for patients to try out lenses ahead of surgery in immersive 3D lifestyle scenarios.
Research
Are blue light-filtering IOLs beneficial for AMD?
Blue light-filtering IOLs demonstrate no protective effect on the risk of developing exudative AMD.Research
Researchers identify high-risk patients prone to IOL dislocation
Trauma, high myopia, and glaucoma may place patients at higher risk for intraocular lens dislocation.
Business
Alcon to acquire STAAR Surgical
The $1.5 billion deal includes STAAR’s FDA-approved implantable collamer lenses; expected to close within 6 to 12 months.
Research
New data finds increased prevalence of refractive surgery among cataract patients
Clinicians may need to consider new ways of calculating IOL power due to prevalence of high myopia and previous refractive surgery.
Pipeline
SpyGlass Pharma raises $75M to advance sustained-release drug delivery platform
Financing to support upcoming phase 3 trials on the company’s long-term delivery system of bimatoprost for glaucoma and OHT treatment.
Products